查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990177

真菌检测套组市场：2026-2032年全球市场预测（按产品类型、技术、应用、最终用户和分销管道划分）

Fungal Testing Kits Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，真菌检测套组市场价值将达到 31.2 亿美元，到 2026 年将成长至 33.4 亿美元，到 2032 年将达到 54 亿美元，复合年增长率为 8.14%。

主要市场统计数据
基准年 2025 31.2亿美元
预计年份：2026年 33.4亿美元
预测年份 2032 54亿美元
复合年增长率 (%) 8.14%

权威的介绍概述了快速且准确的真菌检测在临床医学、环境安全、食品品质和药物监测中的战略重要性。

真菌检测技术的进步和市场动态提升了临床、环境、食品安全和药品品质等领域的诊断能力。本文概述了准确快速的真菌检测对于公共卫生措施、供应链安全和品质保证计划至关重要。此外，本文还重点阐述了技术创新、监管预期和终端用户需求的变化如何相互作用，从而影响真菌检测技术的部署模式和筹资策略。

对技术整合和商业化转型进行全面评估，这种转型重塑了各行业的诊断工作流程、分销策略和使用者采纳。

真菌检测领域正经历一场变革，其驱动力包括技术融合、监管要求的改变以及终端用户需求的不断增长。快速分子技术和先进的免疫检测正与传统培养方法融合，形成兼顾灵敏度和速度的混合工作流程。同时，样品製备、自动化和生物资讯学的进步也使检查室能够在保持严格品管的同时，提升检测能力。

对近期关税变化如何重塑诊断耗材和设备的采购、定价策略和供应链韧性进行详细分析。

2025年，对进口和供应的诊断耗材及设备征收的累积关税调整，对检查室和商业环境中的相关人员的运营和采购产生了切实的影响。关税带来的成本压力促使各方重新检视筹资策略、库存计画和供应商合约。采购者采取的因应措施包括：供应商多元化、尽可能增加在地采购，以及协商签订长期合约以稳定投入成本并降低供应链风险。

将产品类型、底层技术、应用案例、最终用户画像和分销管道趋势与买家需求相匹配的策略性细分洞察。

深入了解市场细分对于根据临床、环境、食品安全和製药领域的用户需求客製化产品开发和上市策略至关重要。产品类型细分包括培养方法、免疫检测和分子检测法。培养方法又分为液体培养基和固体培养基；免疫检测可分为酵素免疫分析法(ELISA) 和横向流动化验；分子检测方法包括恒温环型核酸扩增、次世代定序和聚合酵素链锁反应(PCR) 技术。后者可进一步分为常规 PCR 和即时PCR。每种产品途径都有不同的检验要求、结果取得时间和工作流程影响，这些因素都会影响其在不同检查室环境中的应用。

详细的区域展望揭示了细微的监管差异、基础设施成熟度和贸易趋势如何影响主要全球市场的采用和分销。

区域趋势在真菌检测套组及相关设备的采用、报销机制和供应链设计中发挥着至关重要的作用。美洲地区呈现出多元化的格局：大规模医院系统对先进分子诊断技术的应用与门诊和消费者市场对快速、分散式解决方案的强劲需求并存。该地区的监管和采购流程在促进创新的同时，也强调临床检验以及与实验室资讯系统的互通性。

深入了解决定供应商成功和长期客户参与的竞争定位、伙伴关係模式和业务差异化因素。

真菌检测领域的竞争格局由差异化的产品系列、策略联盟以及可扩展服务模式的投资决定。成熟的试剂和仪器供应商凭藉其广泛的产品线、检验的通讯协定以及丰富的实施经验，保持着市场领先地位，这些优势也促进了耗材和服务合约的交叉销售。同时，灵活的细分市场参与者正透过专注于快速分子检测、用户友好的照护现场(POC) 平台或针对特定检测基质量身定制的高度专业化的环境和食品安全解决方案，不断扩大市场份额。

针对产品组合强化、供应链韧性、监管策略和客户支援提出切实可行的建议，以加速产品采用和成长。

产业领导者应采取多管齐下的策略，既要抓住短期机会，也要增强韧性，以应对未来的挑战。首先，应优先制定组合策略，平衡成熟的培养方法与分子和免疫检测平台的投资，使客户能够选择灵敏度、速度和成本都达到最优的解决方案。其次，应透过多元化采购、区域製造伙伴关係以及库存策略来增强供应链韧性，从而减轻关税波动和物流中断的影响。

高度透明的混合方法调查方法，结合相关人员访谈、第二手资料整合和严格检验，确保了可靠的策略见解。

本研究采用混合方法，结合了对主要相关人员的访谈、有针对性的二手文献综述以及严格的资料检验，以确保研究结果的稳健性和相关性。主要研究包括对临床、环境、食品安全和药物检测领域的实验室负责人、品质保证经理、采购经理和最终用户进行结构化访谈，以了解其营运重点、技术挑战和采购行为。这些访谈深入定性地揭示了工作流程的限制、验证预期和售后支援需求。

我们透过整合技术融合、供应链韧性和细分主导策略的有力结论来指导经营团队决策。

总而言之，真菌检测生态系统正处于技术、法规和商业策略交汇的转折点，重新定义了多个领域的诊断能力。传统培养方法与最先进的分子诊断和免疫检测平台之间的相互作用，正在催生出能够满足灵敏度、速度和营运效率等不同需求的混合工作流程。供应链压力和关税趋势凸显了采购多元化和弹性生产方式对于维持服务连续性的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：真菌检测套组市场：依产品类型划分

  • 培养方法
    • 液体培养基
    • 固体培养基
  • 免疫检测
    • 酵素免疫分析法
    • 横向流动化验
  • 分子
    • 恒温环型核酸扩增
    • 次世代定序
    • 聚合酵素链锁反应
      • 传统的
      • 即时的

第九章：真菌检测套组市场：依技术划分

  • 常规聚合酵素链锁反应
  • 酵素免疫分析法
  • 恒温环型核酸扩增
  • 基质辅助雷射脱附游离飞行法
  • 即时聚合酵素链锁反应

第十章：真菌检测套组市场：依应用领域划分

  • 临床诊断
    • 住院病人
    • 门诊
  • 环境测试
    • 空气
    • 土壤
    • 水
  • 食品安全
    • 乳製品
    • 肉类
    • 农产品
  • 药品品管
    • 药物中的活性成分
    • 最终产品检验

第十一章：真菌检测套组市场：依最终用户划分

  • 一般消费者
  • 医院检查室
  • 独立检测实验室
  • 标准检验组织

第十二章：真菌检测套组市场：依分销管道划分

  • 在线的
  • 离线

第十三章：真菌检测套组市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：真菌检测套组市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：真菌检测套组市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国真菌检测套组市场

第十七章：中国真菌检测套组市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ADT Biotech
  • Bio-Rad Laboratories, Inc.
  • Biomed Diagnostics, Inc.
  • Biosan Laboratories, Inc.
  • Bruker Corporation
  • ELITech Group
  • Eurofins Viracor Inc.
  • F. Hoffmann-La Roche, Ltd.
  • HiMedia Laboratories Pvt. Ltd
  • Lotioncrafter's
  • MCE Chemicals & Equipment Co. , Inc.
  • Merck KgaA
  • Norgen Biotek Corp.
  • PathoNostics BV
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Xiamen Bioendo Technology Co., Ltd.
  • Zymo Research Corporation
Product Code: MRR-7949F058390D

The Fungal Testing Kits Market was valued at USD 3.12 billion in 2025 and is projected to grow to USD 3.34 billion in 2026, with a CAGR of 8.14%, reaching USD 5.40 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.12 billion
Estimated Year [2026] USD 3.34 billion
Forecast Year [2032] USD 5.40 billion
CAGR (%) 8.14%

An authoritative introduction outlining the strategic importance of timely, accurate fungal testing for clinical care, environmental safety, food quality and pharmaceutical oversight

The evolution of fungal testing technologies and market dynamics has elevated diagnostic capability across clinical, environmental, food safety and pharmaceutical quality contexts. This introduction frames the critical importance of accurate, timely fungal detection as a foundational component of public health responses, supply chain safety, and quality assurance programs. It highlights the interplay between technological innovation, regulatory expectations, and shifting end-user priorities that collectively shape adoption patterns and procurement strategies.

Over recent years, stakeholders from hospital laboratories to independent testing services have confronted new challenges including rising incidence of opportunistic fungal infections, heightened scrutiny of environmental controls, and increasing consumer demand for rapid, at-home solutions. Consequently, the landscape now demands sensitivity to assay performance, speed to result, ease-of-use, and integration with laboratory information systems. Furthermore, the introduction of novel molecular and immunoassay platforms has prompted laboratories to reassess workflows, training needs, and capital allocation.

This section sets the stage for deeper analysis by outlining the strategic questions leaders must address: how to balance culture-based tradition with molecular speed, how to validate new technologies within regulatory frameworks, and how to align distribution and commercialization strategies with diverse end-user needs. It provides the contextual foundation for subsequent sections that explore transformative shifts, tariff impacts, segmentation complexities, regional dynamics, competitive behavior, actionable recommendations, methodological rigor, and concluding synthesis.

Comprehensive assessment of technological convergence and commercialization shifts reshaping diagnostic workflows, distribution strategies and user adoption across sectors

The fungal testing landscape is undergoing transformative shifts driven by technology convergence, changing regulatory expectations, and an expanded set of end-user requirements. Rapid molecular techniques and advanced immunoassays are converging with traditional culture-based approaches to create hybrid workflows that prioritize both sensitivity and speed. Simultaneously, improvements in sample preparation, automation, and bioinformatics enable laboratories to scale testing throughput while maintaining stringent quality controls.

Emerging technologies such as loop mediated isothermal amplification and next generation sequencing are altering use cases, enabling point-of-care screening in outpatient settings and more granular pathogen characterization for clinical decision support. In parallel, matrix assisted laser desorption ionization time of flight instrumentation continues to streamline organism identification workflows in centralized labs, reducing time-to-result for many routine applications. Adoption patterns are influenced not only by analytical performance but also by total cost of operation, ease of integration, and availability of validated assay kits.

Market participants are also adapting commercialization strategies to align with omnichannel distribution models. Direct sales remain critical for large hospital systems and reference laboratories, whereas distributors and online channels are increasingly important for decentralized consumers and independent testing facilities. These shifts necessitate flexible business models, enhanced post-sale support, and investment in training and digital tools to support end users across clinical diagnostics, environmental monitoring, food safety, and pharmaceutical quality control.

Detailed analysis of how recent tariff shifts are reshaping sourcing, pricing strategies, and supply chain resilience for diagnostic consumables and instrumentation

In 2025, cumulative tariff adjustments imposed on imports and supplies for diagnostic consumables and instrumentation have introduced tangible operational and procurement implications for stakeholders across laboratory and commercial settings. Cost pressure from tariffs has triggered reassessments of sourcing strategies, inventory planning, and supplier contracts. Buyers have responded by diversifying supplier pools, increasing local sourcing where feasible, and negotiating longer-term agreements to stabilize input costs and mitigate supply chain risk.

Tariff-driven changes have also influenced product positioning and pricing strategies. Suppliers are increasingly packaging bundled solutions that emphasize value through integrated consumables, service contracts, and digital support to justify revised price points. Smaller laboratories and independent testing providers have faced the most acute margin pressure, prompting many to evaluate the trade-offs between in-house testing versus outsourcing to larger reference centers. Simultaneously, some manufacturers have accelerated investments in regional manufacturing or partnered with local distributors to reduce exposure to cross-border levies and logistical delays.

Regulatory compliance and customs classification have become focal points in procurement negotiations, with procurement teams dedicating more resources to tariff classification reviews and documentation. These operational adaptations underscore the need for agility in contract negotiations, robust supplier risk management, and scenario planning to ensure continuity of diagnostic services and adherence to quality standards amidst an evolving international trade environment.

Strategic segmentation insights that map product types, enabling technologies, application use cases, end user profiles and distribution channel dynamics to buyer needs

A nuanced understanding of market segmentation is essential for aligning product development and go-to-market strategies with user needs across clinical, environmental, food safety, and pharmaceutical contexts. Product type segmentation spans culture based approaches, immunoassays, and molecular assays, with culture based methods subdivided into liquid media and solid media formats, immunoassays differentiated by enzyme linked immunosorbent assay and lateral flow assay formats, and molecular approaches encompassing loop mediated isothermal amplification, next generation sequencing, and polymerase chain reaction techniques; the latter further divided into conventional and real time PCR modalities. Each product pathway carries distinct validation requirements, time-to-result characteristics, and workflow implications that influence adoption in different laboratory settings.

Technology segmentation further clarifies user expectations by distinguishing conventional polymerase chain reaction, enzyme linked immunosorbent assay, loop mediated isothermal amplification, matrix assisted laser desorption ionization time of flight, and real time polymerase chain reaction. These technology distinctions inform purchasing decisions based on throughput needs, analytical sensitivity, and capital investment thresholds. Application segmentation reveals divergent use cases: clinical diagnostics separates inpatient and outpatient settings with differing turnaround and regulatory demands; environmental testing breaks into air, soil, and water matrices that require specialized sampling and contamination controls; food safety focuses on dairy, meat, and produce where shelf-life and cross-contamination concerns are paramount; and pharmaceutical quality control covers active pharmaceutical ingredient and finished product testing that demands rigorous method validation.

End user segmentation identifies consumers, hospital laboratories, independent testing laboratories, and reference laboratories as distinct buyer cohorts with unique purchasing cycles, technical competencies, and support requirements. Distribution channel segmentation spans direct sales, distributors, and online channels, each presenting different margins, training responsibilities, and opportunities for recurring revenue through consumables and maintenance. Taken together, these segmentation lenses enable suppliers to prioritize development roadmaps, tailor regulatory submissions, and design commercial models that align with the operational realities of diverse laboratory ecosystems.

In-depth regional perspectives revealing how regulatory nuance, infrastructure maturity and trade dynamics influence adoption and distribution across major global markets

Regional dynamics play a decisive role in technology uptake, reimbursement frameworks, and supply chain design for fungal testing kits and associated instrumentation. The Americas display a heterogeneous landscape where advanced molecular adoption in large hospital systems coexists with strong demand for rapid, decentralized solutions in outpatient and consumer markets. Regulatory and procurement pathways in the region encourage innovation but also place emphasis on clinical validation and interoperability with laboratory information systems.

Europe, Middle East & Africa encompasses varied regulatory and infrastructure maturity levels, with some markets prioritizing centralized reference testing and others investing in point-of-care expansion to improve access. In many countries within this region, environmental testing and food safety remain high priorities due to stringent public health standards and export requirements, leading to selective adoption of advanced identification technologies and robust quality control protocols. Cross-border logistics and trade policies in this region also influence stocking strategies and distribution partnerships.

Asia-Pacific is characterized by rapid capacity expansion, rising investment in laboratory infrastructure, and a growing emphasis on domestic manufacturing to reduce import dependencies. Demand in several markets is driven by strong public health initiatives, food export requirements, and a large pool of hospital and independent laboratories seeking efficiency gains through automation and molecular platforms. Across all regions, local regulatory nuance, reimbursement mechanisms, and infrastructure considerations shape the pace and pattern of adoption for different technologies and commercial models.

Actionable insights on competitive positioning, partnership models, and operational differentiators that determine supplier success and long-term customer engagement

Competitive dynamics in the fungal testing space are defined by differentiated portfolios, strategic collaborations, and investment in scalable service models. Established reagent and instrument providers maintain leadership through broad product ranges, validated protocols, and extensive installed bases that facilitate cross-selling of consumables and service contracts. At the same time, agile niche players are carving market space by focusing on rapid molecular assays, user-friendly point-of-care platforms, or highly specialized environmental and food safety solutions that address specific testing matrices.

Partnerships between assay developers and instrumentation manufacturers have become a common route to accelerate market access and provide customers with integrated solutions that reduce validation burdens. Manufacturing scale and supply chain resilience are increasingly critical differentiators as buyers prioritize supplier reliability and predictable lead times. Companies investing in digital enablement, including cloud-based analytics, instrument connectivity, and remote support capabilities, are gaining traction by lowering barriers to adoption among smaller laboratories and decentralized users.

Intellectual property and regulatory strategy also influence competitive positioning. Firms that invest early in robust clinical and analytical validation are better positioned to win tenders and secure long-term agreements with hospital systems and reference laboratories. Overall, competitive advantage is increasingly anchored in the ability to combine analytical performance with operational value propositions such as workflow efficiency, total cost of ownership clarity, and comprehensive post-sale service.

Practical, high-impact recommendations for strengthening portfolios, supply chain resilience, regulatory strategy and customer support to accelerate adoption and growth

Industry leaders should adopt a multi-pronged approach to capture near-term opportunities while building resilience for future disruptions. First, prioritize portfolio strategies that balance proven culture based methods with investments in molecular and immunoassay platforms, ensuring customers can select solutions optimized for sensitivity, speed and cost. Second, strengthen supply chain resilience through diversified sourcing, regional manufacturing partnerships, and inventory strategies that mitigate tariff-related volatility and logistical disruptions.

Third, enhance customer support models by offering tailored training, remote diagnostics, and bundled service agreements that lower the total cost of ownership for end users. Fourth, pursue regulatory and validation strategies that accelerate adoption across targeted applications, with particular attention to inter-laboratory reproducibility and cross-platform comparability. Fifth, invest in digital tools that streamline data integration, result interpretation, and reporting to support clinical decision-making and compliance in regulated environments.

Finally, adopt a nuanced go-to-market approach that segments accounts by end user type and distribution preference, aligning direct sales efforts with large institutional buyers while leveraging distributors and online channels to reach decentralized laboratories and consumer markets. These steps will position organizations to capture diversified revenue streams, build long-term customer loyalty, and respond nimbly to emergent public health and supply chain challenges.

Transparent mixed-methods research methodology that combines stakeholder interviews, secondary evidence synthesis and rigorous validation to ensure reliable strategic insights

This research is grounded in a mixed-methods approach combining primary stakeholder interviews, targeted secondary literature review, and rigorous data validation to ensure robustness and relevance. Primary research included structured interviews with laboratory directors, quality assurance managers, procurement leads, and end users across clinical, environmental, food safety, and pharmaceutical testing contexts to capture operational priorities, technology pain points, and procurement behaviors. These conversations provided qualitative depth on workflow constraints, validation expectations, and post-sale support needs.

Secondary sources encompassed peer-reviewed literature, regulatory guidance documents, manufacturer technical notes, and industry white papers to triangulate findings and contextualize technological trends. Throughout the study, methodological safeguards were applied including cross-verification of claims across multiple independent sources, review of technical performance metrics where available, and an assessment of regulatory frameworks relevant to assay validation and laboratory accreditation. Data cleaning procedures and sensitivity checks were employed to reduce bias and ensure that conclusions reflect consensus views rather than isolated perspectives.

Limitations are acknowledged and include the variable availability of proprietary performance data and the evolving nature of trade policies which may impact procurement conditions. Still, by combining qualitative insights with systematic document analysis and stakeholder validation, the methodology delivers a credible foundation for strategic decision-making and operational planning.

A compelling conclusion synthesizing technological convergence, supply resilience and segmentation-driven strategies to guide leadership decision-making

In summary, the fungal testing ecosystem is at an inflection point where technology, regulation and commercial strategy intersect to redefine diagnostic capability across multiple sectors. The interplay between traditional culture based practices and modern molecular and immunoassay platforms is creating hybrid workflows that meet diverging needs for sensitivity, speed, and operational efficiency. Supply chain pressures and tariff dynamics have highlighted the importance of diversified sourcing and flexible manufacturing approaches to maintain service continuity.

Segment-specific strategies, informed by product type, technology, application, end user, and distribution channel considerations, will be essential for suppliers seeking sustainable growth. Regional differences in regulatory rigor, infrastructure maturity, and procurement frameworks require tailored approaches rather than one-size-fits-all models. Competitive differentiation will increasingly depend on the ability to provide integrated solutions that combine validated performance with clear total cost of ownership and strong post-sale support.

Leaders that align product pipelines, validation strategies, and commercial models with the operational realities of laboratories and end users will be best positioned to capture value. The research herein equips decision-makers with actionable context to inform strategic planning, investment decisions, and partnership development as the market continues to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fungal Testing Kits Market, by Product Type

  • 8.1. Culture Based
    • 8.1.1. Liquid Media
    • 8.1.2. Solid Media
  • 8.2. Immunoassay
    • 8.2.1. Enzyme Linked Immunosorbent Assay
    • 8.2.2. Lateral Flow Assay
  • 8.3. Molecular
    • 8.3.1. Loop Mediated Isothermal Amplification
    • 8.3.2. Next Generation Sequencing
    • 8.3.3. Polymerase Chain Reaction
      • 8.3.3.1. Conventional
      • 8.3.3.2. Real Time

9. Fungal Testing Kits Market, by Technology

  • 9.1. Conventional Polymerase Chain Reaction
  • 9.2. Enzyme Linked Immunosorbent Assay
  • 9.3. Loop Mediated Isothermal Amplification
  • 9.4. Matrix Assisted Laser Desorption Ionization Time Of Flight
  • 9.5. Real Time Polymerase Chain Reaction

10. Fungal Testing Kits Market, by Application

  • 10.1. Clinical Diagnostics
    • 10.1.1. Inpatient
    • 10.1.2. Outpatient
  • 10.2. Environmental Testing
    • 10.2.1. Air
    • 10.2.2. Soil
    • 10.2.3. Water
  • 10.3. Food Safety
    • 10.3.1. Dairy
    • 10.3.2. Meat
    • 10.3.3. Produce
  • 10.4. Pharmaceutical Quality Control
    • 10.4.1. Active Pharmaceutical Ingredient
    • 10.4.2. Finished Product Testing

11. Fungal Testing Kits Market, by End User

  • 11.1. Consumers
  • 11.2. Hospital Laboratories
  • 11.3. Independent Testing Laboratories
  • 11.4. Reference Laboratories

12. Fungal Testing Kits Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Fungal Testing Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Fungal Testing Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Fungal Testing Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Fungal Testing Kits Market

17. China Fungal Testing Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ADT Biotech
  • 18.6. Bio-Rad Laboratories, Inc.
  • 18.7. Biomed Diagnostics, Inc.
  • 18.8. Biosan Laboratories, Inc.
  • 18.9. Bruker Corporation
  • 18.10. ELITech Group
  • 18.11. Eurofins Viracor Inc.
  • 18.12. F. Hoffmann-La Roche, Ltd.
  • 18.13. HiMedia Laboratories Pvt. Ltd
  • 18.14. Lotioncrafter's
  • 18.15. MCE Chemicals & Equipment Co. , Inc.
  • 18.16. Merck KgaA
  • 18.17. Norgen Biotek Corp.
  • 18.18. PathoNostics B.V.
  • 18.19. Siemens Healthineers
  • 18.20. Thermo Fisher Scientific, Inc.
  • 18.21. Xiamen Bioendo Technology Co., Ltd.
  • 18.22. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL FUNGAL TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FUNGAL TESTING KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FUNGAL TESTING KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES FUNGAL TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA FUNGAL TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FUNGAL TESTING KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LIQUID MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LIQUID MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY SOLID MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY SOLID MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY SOLID MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REAL TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REAL TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REAL TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY AIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY AIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY AIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY SOIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY SOIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY SOIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY WATER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY WATER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY WATER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY DAIRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY DAIRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY MEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PRODUCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PRODUCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PRODUCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY FINISHED PRODUCT TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY FINISHED PRODUCT TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY FINISHED PRODUCT TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONSUMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONSUMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY CONSUMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY INDEPENDENT TESTING LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY INDEPENDENT TESTING LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY INDEPENDENT TESTING LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL FUNGAL TESTING KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GCC FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. GCC FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 257. GCC FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 259. GCC FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 260. GCC FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. GCC FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 264. GCC FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 265. GCC FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 266. GCC FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GCC FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. G7 FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. G7 FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 299. G7 FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 300. G7 FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 301. G7 FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 302. G7 FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. G7 FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. G7 FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 305. G7 FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 306. G7 FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 307. G7 FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 308. G7 FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. G7 FUNGAL TESTING KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. NATO FUNGAL TESTING KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 311. NATO FUNGAL TESTING KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. NATO FUNGAL TESTING KITS MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
  • TABLE 313. NATO FUNGAL TESTING KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 314. NATO FUNGAL TESTING KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 315. NATO FUNGAL TESTING KITS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 316. NATO FUNGAL TESTING KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. NATO FUNGAL TESTING KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. NATO FUNGAL TESTING KITS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 319. NATO FUNGAL TESTING KITS MARKET SIZE, BY ENVIRONMENTAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 320. NATO FUNGAL TESTING KITS MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 321. NATO FUNGAL TESTING KITS MARKET SIZE, BY PHARMACEUTICAL QUALITY CONTROL, 2018-2032 (USD MILLION)
  • TABLE 322. NATO FUNGAL TESTING KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. NATO FUNGAL TESTING KITS MARK